Follow-up data for a further 7 years have accrued since we first described the mortality of employees of the United Kingdom Atomic Energy Authority (UKAEA), . Cancer mortality then was 21% below the national average and prostatic cancer was the only malignancy with clearly increased mortality in relation to radiation exposure. However, the duration of follow-up to the end of 1979 was only 16 years on average, and small numbers of deaths from some cancers yielded imprecise estimates which were consistent with a wide range of effects. In order to increase precision and allow for longer latency, we have continued to collect follow-up data on the entire UKAEA study population, including employees still in service on 1 January 1980. Analyses of mortality data from 1946 to 1986, and cancer registration data from 1971 to 1984, are reported here with special reference to prostatic cancer, other genital tract cancers, and malignancies such as multiple myeloma which have been associated with radiation exposure in other studies of nuclear industry workers (Smith & Douglas, 1986; Gilbert et al., 1989) .
Methods
The design and methods of data collection and validation in the UKAEA mortality study have been described previously and a fully account of the methods used in this report will be published elsewhere (Fraser et The UKAEA's records of deaths in service and among members of their pension scheme provided a cross-check on the completeness of notification of death and sometimes information of assistance in tracing deaths at the NHSCRs. Further checks on the completeness of notification of cancer deaths and random samples of non-cancer deaths were carried out at NHSCR in Southport. Deaths notified in the UKAEA study population were also cross-checked against deaths in radiation workers notified to the National Radiological Protection Board (NRPB) (Kendall. et al., 1992a,b . (Breslow & Day, 1987) .
Rate ratios (RR) adjusted for age, sex, calendar period, establishment and social class, and approximate 95% CIs, were estimated by the method of maximum likelihood using the GLIM computer package (Baker & Nelder, 1982) . Statistical significance of the RRs was tested using the likelihood ratio statistic and checked using the score statistic (Breslow & Day, 1987) . When the total number of deaths contributing to the RR was less than 20, exact confidence intervals and significance levels were generated from the stratum-specific deaths and person-years using the likelihood for binomial data.
For workers with a radiation record, the relation between level of external whole body radiation exposure and mortality was examined without reference to national rates. An overall chi-squared statistic was obtained to test for a linear trend across five levels of exposure stratified by age, sex, calendar period, establishment and social class (Breslow & Day, 1987) . When the resultant test statistic was based on a total number of deaths of 20 or less, probability values were checked using 10,000 simulations as described elsewhere . Changes in cancer risk associated with increasing exposure to radiation were estimated using an additive relative risk model. Excess relative risks and absolute risks (and their 95% CIs) were estimated from this model using maximum likelihood methods described by Gilbert (1989) .
The cancer registration data were analysed using methods similar to those employed for mortality. Cancers first identified through a death certificate as the underlying or an associated cause of death were included in all internal (within workforce) comparisons, the date of death being used as a surrogate for the registration date. Where an ill-defined, secondary or unspecified neoplasm was registered but a primary malignant neoplasm was specified on the death certificate, the date of registration was retained but the primary site was substituted in all internal analyses. For .,o (7, cq (7, 00 t-r-00 en as 00 In order to investigate further the effects of internal and external radiation exposure, the trends in prostatic cancer mortality were re-examined after stratification for radionuclide exposure (Table IV) . Rate ratios for prostatic cancer mortlaity increased with increasing cumulative whole body exposure in men monitored for exposure to any radionuclide CD m C'4 a, C., a.
c, C; C5 6 6 6 C.. 6 6 C; 6 C5 C4 6 6 6 C; 6 .ro- previously (Inskip et al., 1987 (Inskip et al., 1987). in detail in Tables I to IV . The registration analyses reported here were restricted therefore to cancer sites where previous analyses have suggested a relationship between mortality or cancer incidence and radiation exposure, and sites which carry a better prognosis where an examination of cancer registrations might be expected to provide additional information. The extent to which fatal cancers dominated the cancer registrations even for these selected sites is shown in Table VI ; only 429 (27%) individuals with a malignant neoplasm registered in 1971-84 were alive at the end of the study period in December 1986.
When registration rates for employees with a radiation record were compared with rates for other employees there were no significantly raised ratios in either lagged or unlagged analyses (Table VI) . In the latter, the rate ratio of 0.38 (95% CI 0.15-0.98) for testicular cancer was significantly low (P = 0.05). There was no evidence of excess registrations
Discussion
Cancer mortality This report describes mortality from all causes, and cancer in particular, among 39,718 employees of the UKAEA over a 41-year period from 1946 to 1986. The analyses are based on a total of 5,509 deaths, representing an increase of 63% over the number of deaths included in our first report which covered 34 years from 1946 to 1979 . This substantial increase in material permitted more detailed analyses to be carried out for site-specific cancer sites than previously. Comparisons have been made with mortality in the general population of England and Wales, between employees with a radiation record and other employees, and between groups of radiation workers accumulating different levels of external radiation exposure. Mortality has also been examined in workers monitored for internal exposure to tritium, plutonium and other unspecified radionuclides. The of non-fatal breast cancer among women with a radiation record (not shown) as had been the case in the analysis reported in our previous paper (Inskip et al., 1987) .
Cancer registrations and level of cumulative external radiation exposure In unlagged but not lagged analyses there was a significant trend in prostatic cancer registrations with increasing exposure overall (x2 for trend = 6.34, P = 0.01) and at Winfrith alone (X2 for trend = 5.52, P = 0.02). These trends are based on 74 and 23 registrations respectively. In women the unlagged analyses showed trends for all malignant neoplasms (X2 for trend = 5.43, P = 0.02 based on 61 registrations) and for invasive cancer of the uterus (X2 for trend = 4.83, P = 0.03 based on eight registrations) which persisted in the lagged analyses. The uterine cancers were all fatal and thus the findings largely replicate those of the mortality analysis.
In our previous analysis of non-fatal cancers in relation to cumulative whole body exposure (Inskip et al., 1987 ) the trends for skin cancer and bladder cancer were suggestive of an association (X2 = 3.65, P = 0.06 and x2 = 3.57, P = 0.06 respectively). These findings were not replicated when the trends for these two sites were re-examined in subjects registered in 1971-84 who were still alive at the end of the study period in December 1986. The chi-squared trend statistic for skin cancer was 0.12 (P = 0.7) in unlagged analyses and 0.03 (P = 0.9) in lagged analyses based on 71 registrations. The corresponding statistics for bladder cancer were 1.92 (P = 0.2) and 0.97 (P = 0.3) based on 25 registrations. Non-fatal cancers of the prostate were also examined in relation to cumulative whole body exposure but there was no evidence of an association (X2 (unlagged) = 1.91, P = 0.3 and x2 (lagged)= 0.17, P = 0.7, based on 21 registrations). EMPLOYEES, 1946-86 623 results will be discussed here within the context of the previous findings, which have been described fully elsewhere Inskip et al., 1987; Carpenter et al., 1988; Carpenter et al., 1990) .
As previously, overall mortality in the UKAEA workforce was lower than the national average in England and Wales as a consequence of health-related selection and other differences between employed people and the general population (Carpenter et al., 1990 Mortality from cancer of the uterus (including the cervix uteri) in women with a radiation record was increased 4-fold by comparison with other employees. As in the previous report (Smith & Douglas, 1986) and Hanford (Gilbert et al., 1989) workforces was not associated with radiation exposure in UKAEA employees. Indeed, the SMR of 36 (95% CI 10-92) based on four deaths from multiple myeloma in employees with a radiation record was significantly low by comparison with national rates (P = 0.03).
Despite the additional 7 years of follow-up yielding a substantially increased number of cancer deaths, uncertainty associated with the risk estimates remains large (Table V) . For leukaemia, the data are compatible with decreasing risks or increases of up to two deaths per 104 person-years per Sv (or an excess RR of 2.6 per Sv). These risk estimates are very similar to those obtained for US nuclear industry workers (Gilbert et al., 1989) Sv (UNSCEAR, 1988) . Comparing these latter estimates with those relating to nuclear industry workers is questionable because they are likely to be affected by many factors thought to modify the risk of radiation-induced leukaemia. These include the type and duration of exposure and other characteristics of the populations studied. Recent analysis of a much larger population of UK nuclear industry workers (Kendall et al., 1992a,b) (of which the current UKAEA cohorts forms a part) are more appropriate for comparison. This provided an excess RR estimate for leukaemia of 4.3 per Sv (90% CI 0.4 to 13.6).
In contrast with data on US workers, the central risk estimate for all cancers except leukaemia obtained from our data was positive (excess RR per Sv (lagged) = 0.8, 95% CI -1.0 to 3.1). Data from the larger population of UK workers are also suggestive of a generally positive association (excess RR for all malignant neoplasms = 0.5 per Sv, 90% CI -0.1 to 1.2) (Kendall et al., 1992a,b and Sellafield (Smith & Douglas, 1986 ) study populations in a further analysis (the Nuclear Industry Combined Epidemiological Analysis). The combined study population of 75,000 nuclear industry workers will permit the relationship between exposure to low-level ionising radiation and cancer mortality to be estimated with greater precision than was possible in any of the three studies individually.
Cancer morbidity Because of high case fatality for most cancer sites, the findings for cancer registrations largely replicated those of the mortality analyses. In particular, trends in registrations of prostatic cancer and cancer of the uterus with increasing exposure were apparent. The dose-response relationships reported before for non-fatal skin and bladder cancers (Inskip et al., 1987) were not replicated here. The previous findings were based only on cancer registrations in ex-employees who may not have been typical of the workforce as a whole. These new results based on cancer registrations in all employees suggest that the previous findings may have been biased.
Conclusion
This analysis of a much larger body of material than that reported in our first analysis of the UKAEA workforce generally confirms the robustness of the previous findings for most cancer sites. The association between prostatic cancer and both internal and external exposure to radiation is still evident though the dose-response relationship is diminished in strength. Prostatic cancer is under investigation in a casecontrol study within the UKAEA workforce. The association between cancer of the uterus and external radiation exposure which has strengthened in this analysis also warrants further study. There are a number of other statistically significant results, as would be expected by chance alone when such a large number of comparisons are made, but no other cancer sites with consistently exceptional findings. Uncertainty still surrounds estimates of the increase in cancer risk per unit dose. Further combined analyses will provide more precise estimates.
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